Activation of the zymogen of hepatocyte growth factor activator by thrombin - PubMed (original) (raw)
. 1993 Oct 25;268(30):22927-32.
Affiliations
- PMID: 8226803
Free article
Activation of the zymogen of hepatocyte growth factor activator by thrombin
T Shimomura et al. J Biol Chem. 1993.
Free article
Abstract
Hepatocyte growth factor activator (HGF activator) is a serine protease which converts single-chain HGF to the active two-chain form. HGF activator purified from human serum has a molecular mass of 34 kDa and consists of two chains held together by a disulfide bond. The nucleotide sequence of HGF activator cDNA shows that HGF activator is derived from the COOH-terminal region of a precursor of 655 amino acids by proteolytic cleavage of the bonds between Arg372 and Val373 and between Arg407 and Ile408 and that the precursor consists of multiple domains homologous to those observed in blood coagulation factor XII. In this study, we identified the precursor of HGF activator in human plasma using an enzyme-linked immunosorbent assay system. The precursor was purified from plasma by a five-step procedure. The purified precursor did not activate single-chain HGF. The precursor was efficiently cleaved in vitro by thrombin, at the bond between Arg407 and Ile408, in the presence of negatively charged substances. The cleaved precursor activated single-chain HGF. These findings led us to conclude that HGF activator is present in plasma as an inactive zymogen and that the zymogen is activated by the cleavage of the bond between Arg407 and Ile408 by thrombin. Characteristic structural domains in the NH2-terminal region of the zymogen may be involved in the binding of the zymogen to negatively charged substances, which stimulates the activation of the zymogen by thrombin.
Similar articles
- Hepatocyte Growth Factor Activator: A Proteinase Linking Tissue Injury with Repair.
Fukushima T, Uchiyama S, Tanaka H, Kataoka H. Fukushima T, et al. Int J Mol Sci. 2018 Nov 1;19(11):3435. doi: 10.3390/ijms19113435. Int J Mol Sci. 2018. PMID: 30388869 Free PMC article. Review. - Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases.
Mukai S, Fukushima T, Naka D, Tanaka H, Osada Y, Kataoka H. Mukai S, et al. FEBS J. 2008 Mar;275(5):1003-17. doi: 10.1111/j.1742-4658.2008.06265.x. Epub 2008 Jan 25. FEBS J. 2008. PMID: 18221492 - Purification and characterization of hepatocyte growth factor (HGF)-converting enzyme: activation of pro-HGF.
Mizuno K, Tanoue Y, Okano I, Harano T, Takada K, Nakamura T. Mizuno K, et al. Biochem Biophys Res Commun. 1994 Feb 15;198(3):1161-9. doi: 10.1006/bbrc.1994.1164. Biochem Biophys Res Commun. 1994. PMID: 8117273 - Slow thrombin is zymogen-like.
Huntington JA. Huntington JA. J Thromb Haemost. 2009 Jul;7 Suppl 1(S1STATE):159-64. doi: 10.1111/j.1538-7836.2009.03365.x. J Thromb Haemost. 2009. PMID: 19630791 Free PMC article. Review.
Cited by
- Hepatocyte Growth Factor Activator: A Proteinase Linking Tissue Injury with Repair.
Fukushima T, Uchiyama S, Tanaka H, Kataoka H. Fukushima T, et al. Int J Mol Sci. 2018 Nov 1;19(11):3435. doi: 10.3390/ijms19113435. Int J Mol Sci. 2018. PMID: 30388869 Free PMC article. Review. - Safety of Onartuzumab in Patients with Solid Tumors: Experience to Date from the Onartuzumab Clinical Trial Program.
Morley R, Cardenas A, Hawkins P, Suzuki Y, Paton V, Phan SC, Merchant M, Hsu J, Yu W, Xia Q, Koralek D, Luhn P, Aldairy W. Morley R, et al. PLoS One. 2015 Oct 7;10(10):e0139679. doi: 10.1371/journal.pone.0139679. eCollection 2015. PLoS One. 2015. PMID: 26445503 Free PMC article. - Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma.
Betsunoh H, Mukai S, Akiyama Y, Fukushima T, Minamiguchi N, Hasui Y, Osada Y, Kataoka H. Betsunoh H, et al. Cancer Sci. 2007 Apr;98(4):491-8. doi: 10.1111/j.1349-7006.2007.00412.x. Epub 2007 Feb 16. Cancer Sci. 2007. PMID: 17309599 Free PMC article. - Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.
Liu T, Qian WJ, Gritsenko MA, Camp DG 2nd, Monroe ME, Moore RJ, Smith RD. Liu T, et al. J Proteome Res. 2005 Nov-Dec;4(6):2070-80. doi: 10.1021/pr0502065. J Proteome Res. 2005. PMID: 16335952 Free PMC article. - Expression of human kallikrein 1-related peptidase 4 (KLK4) and MET phosphorylation in prostate cancer tissue: immunohistochemical analysis.
Mukai S, Yorita K, Yamasaki K, Nagai T, Kamibeppu T, Sugie S, Kida K, Onizuka C, Tsukino H, Kamimura T, Kamoto T, Kataoka H. Mukai S, et al. Hum Cell. 2015 Jul;28(3):133-42. doi: 10.1007/s13577-015-0114-6. Epub 2015 Apr 11. Hum Cell. 2015. PMID: 25862631
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases